Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

General Anesthesia in a Glucose-6-Phosphate Dehydrogenase Deficiency Child: A Case Report.

Goi T, Shionoya Y, Sunada K, Nakamura K.

Anesth Prog. 2019 Summer;66(2):94-96. doi: 10.2344/anpr-66-01-05.

PMID:
31184943
2.

Double primary recurrent human epidermal growth factor receptor 2-positive breast cancer and esophageal cancer that responded well to chemotherapy.

Yokoi S, Maeda H, Nishino T, Togawa T, Iida A, Goi T.

Int Cancer Conf J. 2018 Oct 1;8(1):17-23. doi: 10.1007/s13691-018-0347-9. eCollection 2019 Jan.

PMID:
31149541
3.

Intravenous Sedation in Arnold-Chiari Malformation With Respiratory Failure.

Shionoya Y, Nakamura E, Goi T, Nakamura K, Sunada K.

Anesth Prog. 2019 Spring;66(1):37-41. doi: 10.2344/anpr-66-01-06.

PMID:
30883227
4.

SMARCB1- and vimentin-positive esophageal carcinoma with undifferentiated components, rhabdoid features, and a good prognosis: a case report.

Nagano H, Izumi T, Kawahara E, Oyama T, Goi T.

Surg Case Rep. 2019 Jan 16;5(1):8. doi: 10.1186/s40792-019-0562-4.

5.

Diagnosis of incarcerated intramesosigmoid hernia aided by multiplanar reconstruction images of multidetector computed tomography: a case report.

Nagano H, Goi T, Taguchi S, Tsubaki T, Uematsu H.

Surg Case Rep. 2018 Oct 20;4(1):128. doi: 10.1186/s40792-018-0535-z.

6.

Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer.

Yoshida Y, Goi T, Kurebayashi H, Morikawa M, Hirono Y, Katayama K.

Oncotarget. 2018 Jul 10;9(53):30079-30091. doi: 10.18632/oncotarget.25706. eCollection 2018 Jul 10.

7.

Acute Small Bowel Perforation Caused by Obstruction of a Novel Tag-Less AgileTM Patency Capsule.

Sawai K, Goi T, Takegawa Y, Ozaki Y, Taguchi S, Kurebayashi H, Suto H.

Case Rep Gastroenterol. 2018 Jun 25;12(2):337-343. doi: 10.1159/000490097. eCollection 2018 May-Aug.

8.

A report of amelanotic malignant melanoma of the esophagus diagnosed appropriately with novel markers: A case report.

Kobayashi J, Fujimoto D, Murakami M, Hirono Y, Goi T.

Oncol Lett. 2018 Jun;15(6):9087-9092. doi: 10.3892/ol.2018.8479. Epub 2018 Apr 12.

9.

RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.

Fujimoto D, Goi T, Koneri K, Hirono Y.

Oncotarget. 2018 Mar 8;9(20):15208-15218. doi: 10.18632/oncotarget.24622. eCollection 2018 Mar 16.

10.

Duplication cyst of the ileum presenting with severe anemia detected by double-balloon endoscopy.

Takegawa Y, Hiramatsu K, Murata Y, Akazawa Y, Saito Y, Ozaki Y, Takahashi K, Naito T, Ofuji K, Matsuda H, Ohtani M, Nemoto T, Suto H, Goi T, Imamura Y, Nakamoto Y.

Endosc Int Open. 2018 Apr;6(4):E395-E398. doi: 10.1055/s-0043-125142. Epub 2018 Mar 29.

11.

Long-term survival in a patient with Virchow's lymph node metastasis of cecal cancer.

Kurebayashi H, Goi T, Morikawa M, Fujimoto D, Koneri K, Murakami M, Hirono Y, Katayama K.

Int Cancer Conf J. 2017 Aug 20;7(1):1-5. doi: 10.1007/s13691-017-0307-9. eCollection 2018 Jan.

12.

Favorable response of colonic mixed adenoneuroendocrine carcinoma to streptozocin monotherapy.

Tagai N, Goi T, Morikawa M, Kurebayashi H, Kato S, Fujimoto D, Koneri K, Murakami M, Hirono Y, Noriki S, Katayama K.

Int Cancer Conf J. 2017 Jun 6;6(4):175-179. doi: 10.1007/s13691-017-0301-2. eCollection 2017 Oct.

13.

Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.

Fujimoto D, Goi T, Hirono Y.

Int J Oncol. 2017 Feb;50(2):448-456. doi: 10.3892/ijo.2016.3822. Epub 2016 Dec 28.

PMID:
28035352
14.

Large-cell neuroendocrine carcinoma of the common bile duct: a case report and a review of literature.

Murakami M, Katayama K, Kato S, Fujimoto D, Morikawa M, Koneri K, Hirono Y, Goi T.

Surg Case Rep. 2016 Dec;2(1):141. Epub 2016 Nov 26.

15.

Clinical influence of anastomotic stricture caused by pancreatogastrointestinalstomy following pancreatoduodenectomy.

Murakami M, Kanji K, Kato S, Fujimoto D, Morikawa M, Koneri K, Hirono Y, Goi T, Yamaguchi A.

Surg Today. 2017 May;47(5):581-586. doi: 10.1007/s00595-016-1412-7. Epub 2016 Sep 8.

PMID:
27631759
16.

Acinar cell carcinoma of the pancreas in childhood.

Morikawa M, Nakazawa T, Kato S, Fujimoto D, Koneri K, Murakami M, Hirono Y, Maeda H, Goi T, Katayama K, Imamura Y, Tanizawa A, Yamaguchi A.

Int Cancer Conf J. 2016 May 19;5(3):140-145. doi: 10.1007/s13691-016-0245-y. eCollection 2016 Jul.

17.

Sericin in the isolating solution improves the yield of islets isolated from the pancreas.

Yokoi S, Murakami M, Morikawa M, Goi T, Yamaguchi A, Terada S.

Cytotechnology. 2016 Dec;68(6):2491-2502. Epub 2016 Apr 28.

18.
19.

Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.

Goi T, Naruse T, Kimura Y, Fujimoto D, Morikawa M, Koneri K, Yamaguchi A.

World J Surg Oncol. 2015 Oct 9;13:296. doi: 10.1186/s12957-015-0704-5.

20.

PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.

Fujimoto D, Ueda Y, Hirono Y, Goi T, Yamaguchi A.

Oncotarget. 2015 Oct 27;6(33):34788-99. doi: 10.18632/oncotarget.5858.

21.

Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.

Goi T, Kurebayashi H, Ueda Y, Naruse T, Nakazawa T, Koneri K, Hirono Y, Katayama K, Yamaguchi A.

Oncotarget. 2015 Oct 13;6(31):31758-66. doi: 10.18632/oncotarget.5565.

22.

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Oct 6;6(30):28790-9. doi: 10.18632/oncotarget.4744.

23.

Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.

Kurebayashi H, Goi T, Shimada M, Tagai N, Naruse T, Nakazawa T, Kimura Y, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Sep 22;6(28):26242-51. doi: 10.18632/oncotarget.4385.

24.

The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Mar 20;6(8):6053-61.

25.

Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer.

Katoh S, Goi T, Naruse T, Ueda Y, Kurebayashi H, Nakazawa T, Kimura Y, Hirono Y, Yamaguchi A.

Anticancer Res. 2015 Jan;35(1):239-44.

PMID:
25550556
26.

Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.

Nakazawa T, Goi T, Hirono Y, Yamaguchi A.

Ann Surg Oncol. 2015 May;22(5):1496-503. doi: 10.1245/s10434-014-4150-3. Epub 2014 Oct 21.

PMID:
25331005
27.

Thrombin conducts epithelial‑mesenchymal transition via protease‑activated receptor‑1 in human gastric cancer.

Otsuki T, Fujimoto D, Hirono Y, Goi T, Yamaguchi A.

Int J Oncol. 2014 Dec;45(6):2287-94. doi: 10.3892/ijo.2014.2651. Epub 2014 Sep 15.

PMID:
25231630
28.

Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S665-71. doi: 10.1245/s10434-014-3765-8. Epub 2014 May 17.

PMID:
24838366
29.

Measures for preventing wound infections during elective open surgery for colorectal cancer: scrubbing with gauze.

Goi T, Ueda Y, Nakazawa T, Sawai K, Morikawa M, Yamaguchi A.

Int Surg. 2014 Jan-Feb;99(1):35-9. doi: 10.9738/INTSURG-D-13-00144.1.

30.

Prokineticin 1 expression in gastrointestinal tumors.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Anticancer Res. 2013 Dec;33(12):5311-5.

PMID:
24324064
31.

Retrocolic roux-en-Y anastomosis for total laparoscopic distal gastrectomy: fix-the-remnant-first technique.

Iida A, Hirono Y, Fujimoto D, Koneri K, Goi T, Katayama K, Yamaguchi A.

Asian J Endosc Surg. 2013 Nov;6(4):333-7. doi: 10.1111/ases.12054.

PMID:
24308598
32.

Protein-bound polysaccharide K reduced the invasive ability of colon cancer cell lines.

Uwafuji S, Goi T, Naruse T, Kurebayashi H, Nakazawa T, Hirono Y, Yamaguchi A.

Anticancer Res. 2013 Nov;33(11):4841-5.

PMID:
24222121
33.
34.
35.

CD44variant exon 9 plays an important role in colon cancer initiating cells.

Kimura Y, Goi T, Nakazawa T, Hirono Y, Katayama K, Urano T, Yamaguchi A.

Oncotarget. 2013 May;4(5):785-91.

36.

Changes in CO2 concentration increase the invasive ability of colon cancer cells.

Obata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A.

Anticancer Res. 2013 May;33(5):1881-5.

PMID:
23645734
37.

Five-year survival of alpha-fetoprotein-producing gastric cancer with synchronous liver metastasis: a case report.

Koneri K, Hirono Y, Fujimoto D, Sawai K, Morikawa M, Murakami M, Goi T, Iida A, Katayama K, Yamaguchi A.

J Gastric Cancer. 2013 Mar;13(1):58-64. doi: 10.5230/jgc.2013.13.1.58. Epub 2013 Mar 31.

38.

The expression of integrins is decreased in colon cancer cells treated with polysaccharide K.

Aso K, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

Int J Oncol. 2013 Apr;42(4):1175-80. doi: 10.3892/ijo.2013.1832. Epub 2013 Feb 19.

PMID:
23427003
39.

The activation of proteinase-activated receptor-1 (PAR1) promotes gastric cancer cell alteration of cellular morphology related to cell motility and invasion.

Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.

Int J Oncol. 2013 Feb;42(2):565-73. doi: 10.3892/ijo.2012.1738. Epub 2012 Dec 14.

PMID:
23242308
40.

Polysaccharide K suppresses angiogenesis in colon cancer cells.

Satoh Y, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

Exp Ther Med. 2012 Sep;4(3):370-374. Epub 2012 Jul 4.

41.

Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.

Tabata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A.

Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6.

PMID:
23135359
42.

[Local resection of a gangliocytic paraganglioma near the papilla of Vater].

Nishino T, Koneri K, Nagano H, Murakami M, Hirono Y, Goi T, Iida A, Katayama K, Ito H, Yamaguchi A.

Nihon Shokakibyo Gakkai Zasshi. 2012 Sep;109(9):1575-83. Japanese.

PMID:
22976227
43.

[A case of stomach metastasis of pleomorphic carcinoma of the lung with hypercalcemia].

Nakazawa T, Hirono Y, Koneri K, Nagano H, Murakami M, Goi T, Iida A, Katayama K, Ito H, Yamaguchi A.

Nihon Shokakibyo Gakkai Zasshi. 2012 Jul;109(7):1204-12. Japanese.

PMID:
22790625
44.

[A case of response to panitumumab as third-line chemotherapy for multiple liver metastases and portal venal tumor embolus of rectal cancer].

Kimura Y, Goi T, Sawai K, Iida A, Katayama K, Yamaguchi A.

Gan To Kagaku Ryoho. 2012 Jun;39(6):967-9. Japanese.

PMID:
22705694
45.

MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer.

Fujishima Y, Goi T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

Int J Oncol. 2012 Apr;40(4):960-4. doi: 10.3892/ijo.2012.1334. Epub 2012 Jan 16.

46.

[Treatment of elderly patients with stage I-III colorectal cancers].

Goi T, Yamaguchi A.

Nihon Rinsho. 2011 Apr;69 Suppl 3:550-3. Japanese. No abstract available.

PMID:
22214021
47.

RIN1-Ras-ERK pathway plays an important role in carcinogenesis in colon cancer cell line LoVo.

Inoue T, Goi T, Hirono Y, Katayama K, Yamaguchi A.

Oncol Res. 2011;19(12):527-34.

PMID:
22812185
48.

The effectiveness of transverse coloplasty in patients with ultra-lower rectal cancer.

Goi T, Honda K, Katayama K, Yamaguchi A.

Int Surg. 2010 Jul-Sep;95(3):210-4.

PMID:
21066998
49.

Survivin-3B gene decreases the invasion-inhibitory effect of colon cancer cells with 5-fluorouracil.

Sawai K, Goi T, Hirono Y, Katayama K, Yamaguchi A.

Oncol Res. 2010;18(11-12):541-7.

PMID:
20939430
50.

The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.

Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.

BMC Cancer. 2010 Aug 19;10:443. doi: 10.1186/1471-2407-10-443.

Supplemental Content

Support Center